Literature DB >> 2973843

Antigen presented in the local lymph node by cells from dimethylbenzanthracene-treated murine epidermis activates suppressor cells.

G M Halliday1, L L Cavanagh, H K Muller.   

Abstract

Application to skin depleted of LC by treatment with the chemical carcinogen DMBA of a dose of contact sensitizer optimal for inducing contact sensitivity activates transferrable suppressor cells. Excision of solvent- or DMBA-treated skin at various times following application of the contact sensitizer DNFB indicated that the fraction of antigen which leaves the skin within the first few hours induces tolerance. An initial signal inducing unresponsiveness, observed within 1/2 hr, was overturned 3-6 hr later. A more permanent tolerogenic signal in the DMBA- but not solvent-treated lymph node resulted from an epidermal cell from DMBA-treated skin presenting antigen to suppressor cells. Therefore it is likely that suppressor cells are activated in DMBA-treated mice by an epidermal cell which migrates to the local lymph node. Local lymph node cells from DMBA-treated mice also have a diminished ability to present antigen in vivo but they do not activate suppressor cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2973843     DOI: 10.1016/0008-8749(88)90119-0

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

1.  Carcinogen-modified dendritic cells induce immunosuppression by incomplete T-cell activation resulting from impaired antigen uptake and reduced CD86 expression.

Authors:  G M Woods; K V Doherty; R C Malley; M J Rist; H K Muller
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  Presentation of antigen to suppressor cells by a dimethylbenz (a) anthracene-resistant, Ia-positive, Thy-1-negative, I-J-restricted epidermal cell.

Authors:  G M Halliday; R C Wood; H K Muller
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

3.  Epidermal Langerhans' cell induction of immunity against an ultraviolet-induced skin tumour.

Authors:  L L Cavanagh; R Sluyter; K G Henderson; R S Barnetson; G M Halliday
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

4.  Topical and oral retinoids protect Langerhans' cells and epidermal Thy-1+ dendritic cells from being depleted by ultraviolet radiation.

Authors:  K K Ho; G M Halliday; R S Barnetson
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

5.  Effects of gliotoxin on Langerhans' cell function: contact hypersensitivity responses and skin graft survival.

Authors:  P C McMinn; G M Halliday; H K Muller
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

6.  Chemical carcinogens and antigens induce immune suppression via Langerhans' cell depletion.

Authors:  G M Woods; M Qu; S J Ragg; H K Muller
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

7.  Protein kinase C transduces the signal for Langerhans' cell migration from the epidermis.

Authors:  G M Halliday; A D Lucas
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

Review 8.  Chemical agents and the immune response.

Authors:  M I Luster; G J Rosenthal
Journal:  Environ Health Perspect       Date:  1993-04       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.